Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Non-skin malignancies after renal transplantation

S Lizakowski, A Dębska-Ślizień, B Imko-Walczuk, J Jaśkiewicz, B Rutkowski

Ann Transplant 2009; 14(1): 56-56 :: ID: 880405


Background: During the last several decades, renal transplantations (RT) have been performed with an increasing success. However, RT recipients are predisposed to greater number of late complications including neoplasia caused by graft-preserving immunosuppressive therapy. The objective of the research was to estimate the number and the type of de novo cancers among kidney grafts recipients.
Material/Methods: We reviewed medical records of 913 patients (568 males and 345 females) who underwent RT in our transplantation centre between 1980 and 2008.
Results: During the follow-up 30 (3.3%) RT recipients were diagnosed with
non-skin malignancies. 4 lymphomas and 26 solid malignancies were recognized (7 genitourinary, 5 lung, 4 gastrointestinal, 3 liver, 2 breast, 1 pancreas, 1 brain, 1 larynx, 1 suprarenal gland and 1 of unknown origin).Affected group included 23 (76%) males and 7 (24%) females, they mean age at diagnosis was 54.3±13 (range 24-79) years. The mean time since transplantation to cancer diagnosis was 66.2±58.9 (range 6-228) months. The immunosuppressive protocol consisted of: prednisone (P) azathioprine (AZA) cyclosporine A (CsA) in 14 (46%) patients, mycophenolate mofetil (MMF) tacrolimus (TAC) in 6 (20%) patients; CsA MMF in 4 (13%) patients, AZA in 1 (3.3%) patient; CsA in 3 (10%); TAC in 1 (3.3%) patient and TAC alone in 1 (3.3%) patient. Twelve (40%) patients died. All patients with lymphoma died (8-44 months after diagnosis). Four (13%) patients lost their grafts due to cancer.
Conclusions: Genitourinary cancer, lung cancer and lymphoma were diagnosed most frequently. Almost 50% of cancer patients received P, AZA and CsA. Life expectancy after cancer diagnosis was short.

Keywords: Kidney Transplantation

Add Comment 0 Comments

In Press

12 Feb 2024 : Original article  

No Prognostic Impact of Graft-to-Recipient Weight Ratio on Hepatocellular Carcinoma Recurrence Following Li...

Ann Transplant In Press; DOI: 10.12659/AOT.942767  

21 Feb 2024 : Original article  

Use of LCP-Tacrolimus (LCPT) in Kidney Transplantation: A Delphi Consensus Survey of Expert Clinicians

Ann Transplant In Press; DOI: 10.12659/AOT.943498  

Most Viewed Current Articles

05 Apr 2022 : Original article  

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

22 Nov 2022 : Original article  

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358